BDBM50214279 (5R,8R,11S)-5-[(3-chlorophenyl)methyl]-8-(propan-2-yl)-11-[(1,4,5,6-tetrahydropyrimidin-2-ylamino)methyl]-3,4,5,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-2H-1,4,7,10,13-benzoxatetrazacyclooctadecine-6,9,12-trione::CHEMBL277329

SMILES: [#6]-[#6](-[#6])-[#6@H]-1-[#7]-[#6](=O)-[#6@@H](-[#6]-c2cccc(Cl)c2)-[#7]-[#6]-[#6]-[#8]-c2ccccc2-[#6]-[#6]-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]\[#7]=[#6]-2\[#7]-[#6]-[#6]-[#6]-[#7]-2)-[#7]-[#6]-1=O

InChI Key: InChIKey=ZKKSOCYZPAWTOY-FULLSBAXSA-N

Data: 1 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50214279   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Motilin receptor (Homo sapiens (Human))	BDBM50214279 ((5R,8R,11S)-5-[(3-chlorophenyl)methyl]-8-(propan-2...) Show SMILES [#6]-[#6](-[#6])-[#6@H]-1-[#7]-[#6](=O)-[#6@@H](-[#6]-c2cccc(Cl)c2)-[#7]-[#6]-[#6]-[#8]-c2ccccc2-[#6]-[#6]-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]\[#7]=[#6]-2\[#7]-[#6]-[#6]-[#6]-[#7]-2)-[#7]-[#6]-1=O Show InChI InChI=1S/C32H44ClN7O4/c1-21(2)28-31(43)39-26(20-38-32-36-14-7-15-37-32)29(41)35-13-6-10-23-9-3-4-12-27(23)44-17-16-34-25(30(42)40-28)19-22-8-5-11-24(33)18-22/h3-5,8-9,11-12,18,21,25-26,28,34H,6-7,10,13-17,19-20H2,1-2H3,(H,35,41)(H,39,43)(H,40,42)(H2,36,37,38)/t25-,26+,28-/m1/s1	Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	87	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Tranzyme Pharma Inc. Curated by ChEMBL					Assay Description Displacement of [125I]-motilin from human motilin receptor expressed in CHO cells				Bioorg Med Chem Lett 17: 4187-90 (2007) Article DOI: 10.1016/j.bmcl.2007.05.043 BindingDB Entry DOI: 10.7270/Q2GF0T62
					More data for this Ligand-Target Pair